GAO Urges More Focus On Medicare Home Dialysis Costs
This article was originally published in The Gray Sheet
The Government Accountability Office issued a report urging CMS to improve the reliability of its cost data on home dialysis versus in-center dialysis, and to consider revising` rates to remove disincentives for the former. GAO also suggested expanding the statutory Kidney Disease Education benefit, but HHS said that is not in the president's budget.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.